共 50 条
Resveratrol: review on therapeutic potential and recent advances in drug delivery
被引:205
|作者:
Pangeni, Rudra
[1
]
Sahni, Jasjeet K.
[2
]
Ali, Javed
[2
]
Sharma, Shrestha
[1
]
Baboota, Sanjula
[2
]
机构:
[1] Jamia Hamdard, Fac Pharm, Dept Pharmaceut, New Delhi, India
[2] Hamdard Univ Jamia Hamdard, Dept Pharmaceut, New Delhi 110062, India
关键词:
antioxidant;
bioavailability;
resveratrol;
stilbene;
PROTECTS DOPAMINERGIC-NEURONS;
RED WINE;
IN-VITRO;
ANTIOXIDANT ACTIVITY;
NITRIC-OXIDE;
POLYGONUM-CUSPIDATUM;
HEALTHY-VOLUNTEERS;
PHENOLIC-COMPOUNDS;
TRANS-RESVERATROL;
HYPERTENSION;
D O I:
10.1517/17425247.2014.919253
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Introduction: Natural products have seen a wide range of acceptability for the prevention and treatment of diseases throughout history. Resveratrol, a member of the stilbene family, has been found to potentially exhibit anticancer, antiangiogenic, immunomodulatory and cardioprotective activities as well as being an antioxidant. This is in addition to its usefulness in the treatment of neurodegenerative disease, diabetes and cardiac ailments. Currently, various studies have revealed that resveratrol is a potential drug candidate with multi-spectrum therapeutic application. Areas covered: This review aims to describe the various studies supporting the wide range of pharmacological activities of resveratrol. In addition, it includes a section devoted to discussing the challenges associated with the drug and strategies to improve the properties of resveratrol such as solubility, stability and bioavailability. Expert opinion: Resveratrol demonstrated its ability to be a potential drug candidate for the treatment of different ailments due to its potent antioxidant properties. To improve the drug stability, increase the bioavailability and minimize side-effects of resveratrol, novel drug delivery systems have been formulated to bring this potential candidate to the first line of disease treatment.
引用
收藏
页码:1285 / 1298
页数:14
相关论文